| Filed | Form | Description | |
|---|---|---|---|
| 4/10/25 | DEF 14A | DEF 14A | → |
| 3/31/25 | PRE 14A | PRE 14A | → |
| 4/8/24 | DEF 14A | DEF 14A | → |
| 4/7/23 | DEF 14A | DEF 14A | → |
| 3/27/23 | PRE 14A | PRE 14A | → |
| 4/8/22 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/10/26 | 4 | PRIMARY DOCUMENT | → |
| 3/10/26 | 4 | PRIMARY DOCUMENT | → |
| 3/10/26 | 4 | PRIMARY DOCUMENT | → |
| 3/5/26 | 4 | PRIMARY DOCUMENT | → |
| 3/2/26 | 4 | PRIMARY DOCUMENT | → |
| 3/2/26 | 4 | PRIMARY DOCUMENT | → |
| ↓ | |||
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.